Comparative Effectiveness of Tocilizumab with either Methotrexate or Leflunomide in the Treatment of Rheumatoid Arthritis

• Javier Narváez ,

  * E-mail: fjnarvaez@bellvitgehospital.cat

  Affiliation Department of Rheumatology, Hospital Universitario de Bellvitge-IDIBELL, Barcelona, Spain

  ⨯
• César Díaz-Torné,

  Affiliation Rheumatology Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  ⨯
• Berta Magallares,

  Affiliation Rheumatology Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  ⨯
• Maria Victoria Hernández,

  Affiliation Department of Rheumatology, Hospital Clínic de Barcelona-IDIBAPS, Barcelona, Spain

  ⨯
• Delia Reina,

  Affiliation Deparment of Rheumatology, Hospital de Sant Joan Despí, Consorci Sanitari Integral, Barcelona, Spain

  ⨯
• Héctor Corominas,

  Affiliation Deparment of Rheumatology, Hospital de Sant Joan Despí, Consorci Sanitari Integral, Barcelona, Spain

  ⨯
• Raimon Sanmartí,

  Affiliation Department of Rheumatology, Hospital Clínic de Barcelona-IDIBAPS, Barcelona, Spain

  ⨯
• Arturo Rodriguez de la Serna,

  Affiliation Rheumatology Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  ⨯
• Josep Maria Llobet,

  Affiliation Rheumatology Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  ⨯
• Joan M. Nolla

  Affiliation Department of Rheumatology, Hospital Universitario de Bellvitge-IDIBELL, Barcelona, Spain

  ⨯